L. Felton

发表

Characterisation of a K390R ITK Kinase Dead Transgenic Mouse – Implications for ITK as a Therapeutic Target

M. Fulleylove, R. Solari, B. Hayes, 2014, PloS one.

Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines

V. Perry, J. Rawlins, R. Deacon, 2007, Brain, Behavior, and Immunity.

CCL20 neutralization by a monoclonal antibody in healthy subjects selectively inhibits recruitment of CCR6+ cells in an experimental suction blister

M. Herdman, S. Zamuner, D. Robertson, 2017, British journal of clinical pharmacology.

Immune-to-brain signalling: The role of cerebral CD163-positive macrophages

V. Perry, I. Galea, T. Newman, 2008, Neuroscience Letters.

The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C)

Colm Cunningham, V. Perry, C. Cunningham, 2007, Brain, Behavior, and Immunity.

Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease.

P. Jones, P. Rowland, N. Parr, 2015, Journal of medicinal chemistry.

MCP-1 and murine prion disease: Separation of early behavioural dysfunction from overt clinical disease

V. Perry, C. Cunningham, D. Boche, 2005, Neurobiology of Disease.

CHAPTER 20 – The Interaction between Brain Inflammation and Systemic Infection

V. Perry, L. Felton, 2007 .

Report of the 2005 RSPCA/UFAW Rodent Welfare Group meeting

D. Wells, R. Hubrecht, M. Maconochie, 2006, Lab Animal.

Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP‐1‐deficient mice prior to leucocyte recruitment

V. Perry, P. Hughes, L. Felton, 2006, The European journal of neuroscience.

Biochemistry: Role of PQQ as a mammalian enzyme cofactor?

C. Anthony, L. Felton, 2005, Nature.